Most of the information concerning possible teratogenic effects of Bendectin is derived from
uncontrolled case reports. 3-8 As Bendectin has been widely used since its introduction in …

To clarify the association of Bendectin and other drugs used in early pregnancy with the
occurrence of congenital heart disease, we interviewed 298 mothers of children with …

The results of a survey done at the federal Center for Disease Control (CDC), Atlanta, do not
support recent allegations that Bendectin (Merrell-National Laboratories), a drug commonly …

The risks of birth defects previously associated with Bendectin use in early pregnancy were
evaluated in a case-control study of malformed infants whose mothers were interviewed in …

The relationship between Bendectin exposure during the first trimester of pregnancy and the
occurrence of congenital malformations was prospectively studied in 31,564 newborns …

We investigated the incidence of birth defects in the offspring of women who took Bendectin
during pregnancy. Copies of all prescriptions issued for Bendectin in two Cities, Leeds and …

The embryotoxic and teratogenic potential of Bendectin was assessed in this double‐blind
study in the cynomolgus monkey (Macaca fascicularis). Bendectin was administered orally …

The Food and Drug Administration (FDA) has decided to take another look at all studies to
date that might bear on the question of whether Bendectin causes birth defects. Bendectin is …

As part of a prospective study investigating maternal characteristics and habits during
pregnancy and their impact on fetal development, 1,690 mother/infant pairs were studied. Of …

The maternal use of Bendectin (Debendox) in the first trimester of pregnancy was examined
in a case-control (n= 1,427 and 3,001, respectively) study of malformed infants whose …